Compound Detail
CHEMBL4292583
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
C=CC(=O)N(C)[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(CCN4CCCC4)cc3)n2)C1
Basic Information
| ChEMBL ID | CHEMBL4292583 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | AAZLLXXSMCDQCH-NRFANRHFSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
462.6
MW (Da)
2.79
ALogP
6
HBA
2
HBD
94.8
PSA (Ų)
0.56
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 8.89
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase BTK CHEMBL5251 | IC50 | 8.89 | 8.14 | 1.3 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Tyrosine-protein kinase BTK | IC50 | = | 1.3 | nM | 8.89 | Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 ... | 30290988 |
| Tyrosine-protein kinase BTK | IC50 | = | 41.0 | nM | 7.39 | Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human PBMC assessed ... | 30290988 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30290988 | 10.1016/j.bmcl.2018.09.033 | Tyrosine-protein kinase BTK | 2 |
| 30290988 | 10.1016/j.bmcl.2018.09.033 | ADMET | 2 |
Data from ChEMBL 36 via Core Engine